A federal appeals court Tuesday overruled an FTC decision that aimed to prevent drug patent holders from paying generic makers to keep cheaper drug versions off the market. In a big victory for pharmaceutical giant Schering-Plough Corp., the 11th Circuit ruled that the December 2003 FTC decision would weaken drug companies' ability to defend their patents. The decision also suggests that the FTC's position would give patent holders less certainty in settling cases out of court.
March 11, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Where the region's top lawyers, law firms and in-house teams will gather to celebrate their most stellar achievements of the year.
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Looking for an Associate Attorney with 2 to 5 years experience to handle Labor and Employment Law, Pension Appeals and Workers Compensation....
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Regional mid-sized firm with diverse civil litigation practice seeking hardworking and dedicated attorneys with 1-5 years experience for it...
Lawyers of Distinction would like to announce...
Snyder Sarno D'Aniello Maceri & daCosta would like to announce that...
COLE SCHOTZ P.C. WELCOME HONORABLE GARRY S. ROTHSTADT, J.A.D. (RET.)
